Trial Profile
An Extension Study of LON002 in Patients With Cancer
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 06 Jun 2017
Price :
$35
*
At a glance
- Drugs Artemether (Primary)
- Indications Cancer
- Focus Adverse reactions
- Sponsors LondonPharma
- 21 Mar 2015 New trial record